Mayo Clinic Licenses Expression Pathology Technology for MS-based Amyloidosis Assay | GenomeWeb

This story originally ran on Nov. 18.

Expression Pathology has licensed non-exclusive rights to its Liquid Tissue patent to the Mayo Clinic for the diagnosis of amyloidosis in formalin-fixed paraffin-embedded tissue, the Rockville, Md.-based sample prep company announced on Tuesday.

Financial terms of the deal were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.